Discovering the link between bicuspid aortic valve and aortic aneurysms: genetic or hemodynamic? by Habchi, Karam
Boston University
OpenBU http://open.bu.edu
Theses & Dissertations Boston University Theses & Dissertations
2015
Discovering the link between
bicuspid aortic valve and aortic
aneurysms: genetic or
hemodynamic?
https://hdl.handle.net/2144/16108
Boston University
BOSTON UNIVERSITY 
SCHOOL OF MEDICINE 
 
 
 
 
 
Thesis 
 
 
 
 
DISCOVERING THE LINK BETWEEN BICUSPID AORTIC VALVE AND 
AORTIC ANEURYSMS: GENETIC OR HEMODYNAMIC? 
 
 
 
by 
 
 
KARAM HABCHI 
B.S., B.A., Providence College, 2012 
 
 
 
 
 
 
 
Submitted in partial fulfillment of the 
requirements for the degree of 
Master of Science 
2015
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© 2015 by 
Karam Habchi 
All rights reserved 
Approved by 
 
 
 
 
 
 
 
 
First Reader  ________________________________________________ 
   Linda Heffner, Ph.D., M.D. 
   Professor of Obstetrics and Gynecology 
 
 
 
 
 
 
Second Reader ________________________________________________ 
   Simon Body, M.B., CH.B. 
   Associate Professor of Anesthesia 
   Harvard Medical School 
 
 
 
 
 
 
 
 
 
 
	  	   iv 
DISCOVERING THE LINK BETWEEN BICUSPID AORTIC VALVE AND 
AORTIC ANEURYSMS: GENETIC OR HEMODYNAMIC? 
KARAM HABCHI 
ABSTRACT 
 
Objectives 
 The association between bicuspid aortic valves and aortic aneurysms has 
been well documented. In order to better understand this association, this study 
sought to accomplish two goals. The first was to determine if there was any 
correlation between specific bicuspid aortic valve phenotypes and aortic 
aneurysms. The second goal was to determine if the association between 
bicuspid aortic valve disease and aortic aneurysms has a genetic or 
hemodynamic cause.  
 
Methods 
 For the non-genetic portion of the study, we used echocardiogram and 
surgical records to classify the phenotypes of the aortic valve and the aorta of 
434 patients. We then evaluated the correlation between valve morphotype and 
aortic aneurysm phenotype. For the genetic portion, we used a genome wide 
association study on 452 patients to find genes that could potentially be 
responsible for aortic aneurysms. These were then compared with genes 
suspected of causing bicuspid aortic valve to determine if there is a common 
genetic link between the two disorders. 
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Results 
 We observed a significant association between bicuspid aortic valve and 
aortic aneurysms; however we did not find any significant association between 
the different bicuspid aortic valve phenotypes and aortic aneurysm phenotypes.  
For the genome wide association study, we identified genes that could potentially 
be responsible for causing aortic aneurysms; however, none of the suspected 
markers were considered statistically significant. Also none of the identified 
genes matched to the genes suspected of causing bicuspid aortic valve. 
 
Conclusion 
 While the results were not as expected, the study provided us with 
information to better understand the relationship between bicuspid aortic valves 
and aortic aneurysms. According to the results of the current study, patients with 
bicuspid aortic valve are more likely to develop an aortic aneurysm but specific 
phenotype has no effect on where the aneurysm occurs in the aorta. The 
increased frequency of aortic aneurysms in bicuspid valve patients is most 
probably due to a combination of altered hemodynamics and genetic effects. In 
order for this information to be useful in the clinical setting, the methods of this 
study should be repeated in a larger cohort to make sure the results are 
accurate.  
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INTRODUCTION 
 
The aortic valve and the ascending aorta 
The aortic valve is a semilunar valve composed of three leaflets or cusps 
(left, right, and non coronary). Its function is to maintain unidirectional arterial flow 
by preventing regurgitation of blood from the aorta back into the left ventricle 
during diastole. During systole, as the pressure in the left ventricle exceeds the 
pressure in the aorta, the aortic valve opens and allows the left ventricle to eject 
blood into the aorta; resulting in organ perfusion.  The tri-leaflet structure of the 
valve is an optimal engineering configuration that allows high-velocity flow with 
minimal pressure loss across the valve during systole, while having perfect 
occlusion during diastole.  Leonardo da Vinci first recognized this fundamental 
engineering principle in the early 1500s. 
 
 
 
  
 
 
 
Figure 1. The aortic valve. The orientation of the aortic valve during systole 
(open) and diastole (closed) (Figure taken from AllinaHealth). 
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The aorta is the main artery of the systemic circulation.  Histologically the 
aorta can be broken up into three layers. The innermost layer is termed the 
intima and is made up of the endothelium and it underlying elastic lamellae.  Its 
function is to create a non-thrombogenic surface to minimize activation of the 
coagulation and inflammatory pathways. The thickest and middle layer of the 
aorta is termed the media and is made up of both smooth muscle cells positioned 
perpendicular to the lumen and an extensive amount of elastic tissue. The elastic 
proteins of the aorta, composed of proteins such as collagen, elastin, fibrillin, 
etc., are secreted and maintained by the smooth muscle cells of the tunica media 
(Stegemann et al., 2004).  The principal function of the tunica media is to provide 
Figure 2. The Sections of the Aorta. The aorta can be broken down into 
several different sections. The ascending aorta is made up of the annulus, aortic 
root, sinotubular junction, and ascending thoracic aorta (Figure taken from 
National Health Service). 
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structural integrity to the aorta allowing the aorta to stretch during systolic 
pressure increases. The outermost layer is termed the tunica adventitia and is 
made up of collagen and a supporting elastic layers.  
Anatomically the aorta is divided into several sections based on its 
anatomy: the ascending aorta, the aortic arch, the descending aorta, and the 
abdominal aorta. The ascending aorta begins at the aortic valve, forming an 
aortic root where the coronary arteries take their origin, with a tulip-like expansion 
that appears to have an optimal design for blood flow through the aortic valve.  
The opening from the left ventricle into the aorta (at the level of the aortic valve) 
is termed the annulus, the widest part of the aortic root is termed the sinus of 
Valsalva, and the transition from the aortic root to the tubular proximal ascending 
aorta is termed the sinotubular junction.  
 
Bicuspid aortic valve 
The normally tri-leaflet valve aortic valve is occasionally formed with two 
leaflets resulting in a bicuspid valve. The bicuspid aortic valve (BAV) is the most 
common congenital cardiac anomaly, with an incidence of 0.9% to 1.5% in the 
general population and is more frequent in males and Caucasians (Della Corte et 
al., 2014). Clinically a patient with BAV can be diagnosed with three different 
phenotypes depending on which two leaflets are fused, each with its own distinct 
morphological appearance and physiological effects. These groups are defined 
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by the fusion of two leaflets of the aortic valve and they are Left-Right fusion (L-
R), Right-Non Coronary fusion (R-NC), and Non Coronary-Left fusion (NC-L). 
 
 
Pure or true BAV presents with two, usually completely symmetrical cusps 
(Figure 3E). The fusion can be either vertical or horizontal and it can fall into any 
of the three phenotypes listed above. However this type accounts for only 7% of 
BAV patients (Sievers et al., 2007). The remaining patients with BAV present 
with a non-symmetric valve (Figures 3A, B, C). During these patients’ embryonic 
development, two leaflets fuse creating a single leaflet that is usually much 
greater in size than the remaining, non-fused leaflet with a fibrous ridge (a raphe) 
Figure 3. Different phenotypes of bicuspid valves. A, L-R BAV. B, R-NC BAV. 
C, NC-L BAV. D, L-R BAV with two equal sized leaflets. E, L-R true BAV. F, L-R 
BAV with incomplete raphe (Figure taken from Mechelena et al., 2014).	  
A                                 B                               C 
 
 
 
 
 
 
 
D                                  E                                F 
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marking the fusion of the two leaflets. L-R fusion is the most common type and is 
present in 72% of patients with BAV. R-NC fusion is seen in about 25% of 
patients and NC-L fusion is seen in about 3% of patients. In about 1% of the BAV 
population, a combination of both L-R fusion and R-NC fusion results in a valve 
that appears to be a single leaflet, called a unicuspid valve (Sievers et al., 2007). 
These categories are clinically important because of the differing physiological 
and hemodynamic effects of each BAV type. 
While L-R, R-NC, and NC-L are the major classification groups used for 
BAV patients, additional anatomical and physiological characteristics are used to 
describe the valve structure and its function. These include leaflet symmetry, 
raphe completeness, valve incompetence, stenosis, and/or calcification. Leaflet 
symmetry is based on the size of the two cusps and in the majority of BAV 
patients they are asymmetric. Raphe completeness describes the appearance of 
a raphe and can be either complete or incomplete.  Incompetence of the aortic 
valve occurs when the leaflets fail to coapt (close completely) during diastole 
resulting in regurgitant flow back through the valve in diastole. Aortic stenosis 
occurs when the aortic valve is markedly calcified, thickened and fails to open 
fully during systole resulting in turbulent flow and pressure loss. 
 
Ascending aortic aneurysms 
An aortic aneurysm is an abnormal widening, usually by more than 50% of 
the normal diameter, of a portion of the aorta due to degeneration of the media of 
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the aortic wall (Goldinger et al., 2014). Aortic aneurysms can occur anywhere on 
the entire length of the aorta however 60% of aortic aneurysms involve the aortic 
root or the proximal ascending aorta (Isselbacher et al., 2005). On a cellular 
level, medial degeneration results from the injury and loss of smooth muscle cells 
and degradation of the elastic fibers (Isselbacher et al., 2005). This leads to a 
decrease in the vessel wall integrity and decreases the aorta’s ability to manage 
pulsatile pressure changes. As distensibility decreases, the aortic wall will 
eventually reach its tensile limit, which can lead to aortic dissection or rupture.  
Aortic dissection is the separation of the planes of the aorta, initially 
between the intima and medial portions that leads to intramural hemorrhage in 
the aorta and can eventually lead to aortic rupture. Aortic dissection is a life-
threatening condition with a grim prognosis and has been described as “the most 
devastating complication of thoracic aortic disease” (Goldinger et al., 2014). 
Once the aorta has ruptured, less than half of patients survive. Because aortic 
aneurysm and dissection are so lethal, it is important to identify patients who 
suffer from aortic aneurysm and to determine ways to predict and prevent 
dissection and rupture.  
Measurement of aortic dimensions is normally performed using 
echocardiography or computed tomography imaging; however, determining 
whether or not a patient has developed an aortic aneurysm is more difficult as 
there is usually no longitudinal imaging for a single patient.  Thus definitions of 
aortic aneurysm rely on population means, adjusted for age and patient size.  
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Usually clinicians use a normalizing formula that requires a patient’s BSA to 
determine if the aorta is aneurysmal and some even use a standard number of 
35 millimeters to determine whether or not there is an aneurysm present (Roman 
et al., 1989). However it may be more useful to develop a better method of 
normalizing healthy aortic diameter in order to determine if the patient is at risk of 
an aortic aneurysm (Davies et al., 2006).  
In an attempt to classify patients based on their ascending aortic 
aneurysm phenotype, three classification methods have been proposed. The 
method most commonly used is the one proposed by Schaefer et al. (2007). This 
method defines the shape of the aorta by considering the dimensions of the 
ascending aorta sections regardless of dilatation. This method uses three 
classes: the N shape (ascending aorta < sinuses > STJ), the A shape (ascending 
aorta > sinuses > STJ), and the E shape (sinuses < STJ, regardless of ascending 
aorta size). A second classification scheme proposed by Park et al. (2011) 
depends of the appearance in dilatation at the root, the proximal ascending aorta, 
or both. This method also uses three classes and they are: type 1 (dilatation of 
the ascending aorta only), type 2 (dilatation at both the proximal ascending aorta 
and the root), and type 3 (dilatation of the root only). The most recent 
classification method was proposed by Della Corte et al. (2013). This method 
uses only two classification types and they are: root phenotype or ascending 
phenotype (depending on which portion is predominantly involved).  
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Figure 4.Different phenotypes of ascending aortic aneurysms. Picture 
representation of the different classification systems for ascending aortic 
aneurysm phenotypes (Figure taken from Della Corte et al., 2014). 
	  	   9 
A higher prevalence of ascending aortic aneurysm in patients with a 
bicuspid aortic valve 
There is an association between bicuspid aortic valves and aortic 
aneurysm and aortic dissection (Schaefer et al., 2007). As a group, BAV patients 
have larger average measurements in each section of the aorta (annulus, sinus 
and proximal ascending aorta) when compared to patients with tricuspid aortic 
valves (Nkomo et al., 2002). In addition, it has been noted that specific BAV 
phenotypes have a tendency to lead to a specific aortic aneurysm phenotype. 
(Della Corte et al., 2014). Patients with the most common form of BAV, R-L 
fusion, have a higher incidence of aortic root aneurysms (Schaefer et al., 2007). 
The R-N BAV phenotype has an association with proximal ascending aortic 
aneurysms. In a study of 622 BAV patients, R-L phenotype was associated with 
dilatation at the sinus in 41% of patients versus 22% of patients with R-N 
phenotype. Fifty six percent of patients with R-L phenotype had dilatation at the 
ascending aorta where as 68% of patients with R-N phenotype had this type of 
dilatation (Della Corte et al., 2014). These studies show the importance of 
consistent classification and terminology for both researchers and clinicians who 
study BAV. Clearly not all BAV patients are the same and each requires different 
treatment and management based on phenotype and other factors, including 
age, sex, body surface area, etc. Unfortunately, a recent survey among cardiac 
surgeons has shown that not all clinicians are aware of the findings of studies like 
the one above (Della Corte et al., 2014). According to the aforementioned 
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survey, “only 15% of the respondents were aware that the pattern of valve leaflet 
fusion is associated with a unique pattern of aortic dilatation”.  
Histologically, it has been shown that patients with BAV have accelerated 
deterioration of the aortic wall (Schmid et al., 2002). Patients with BAV showed a 
greater amount of infiltrating leukocytes and depleted numbers of smooth muscle 
cells due to apoptosis. Tissue samples from aneurysmal aortas in BAV patients 
showed expression of apoptotic mediators perforin and Fas/FasL, both of which 
were not present in normal aortic tissue. Researchers have also found increased 
destruction of the elastic laminae in the aortic wall of BAV patients. All of these 
findings have direct correlation with increased incidence of aortic aneurysm 
(Schmid et al., 2002). Mediators of apoptosis secreted by infiltrating leukocytes 
caused increased apoptosis of the smooth muscle cells, which are normally 
responsible for maintenance of the connective tissue in the media of the wall of 
the aorta. In turn, this causes an alteration of the extra cellular matrix leading to 
weakening of the elastic and tensile properties of the aorta potentially resulting in 
aortic aneurysm and dissection (Forte et al., 2013).  
While there is little debate on the correlation between BAV and aortic 
aneurysm, there is debate among clinicians and researchers regarding the 
etiology of aortic aneurysms; whether there may be hemodynamic causes of 
aortic aneurysm that act independently of the genetic causes of aortic aneurysm. 
BAV prevalence is “nearly 10-fold higher in primary relatives of patients with BAV 
than in the general population” (Prakash et al., 2014). Although the genetic 
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causes of BAV have not been clearly identified, by studying familial pedigrees it 
is believed that BAV is inherited in an autosomal dominant fashion. Genes such 
as NOTCH1, ACTA2 and a few others have been determined to play a part in 
causing BAV; however, it is not entirely clear how much influence these genes 
have and whether or not they work in conjunction with other, currently 
unidentified, genes (Prakash et al., 2014). Researchers are continuously 
conducting studies with large cohorts of BAV patients to uncover more 
information about the genetics involved in this disorder.  
As investigators continue to look for genes that cause BAV, it has been 
speculated by some that these same genes are also responsible for some of the 
complications associated with BAV, specifically aortic aneurysm (Prakash et al., 
2014). Although specific genes such as FBN1 have been linked to aortic 
aneurysms, these are different from the genes that are believed to be 
responsible for BAV. However, there is evidence that suggests that the genes 
that cause BAV could also be directly linked to aortic aneurysms as well. Two 
arguments in favor of a genetic correlation between BAV and aortic aneurysms 
are the number of BAV patients who develop aneurysms and the similar 
embryological origin of both the aortic valve and the ascending aorta. 
Researchers who believe there is a genetic link cite the fact that “because BAV 
and TAAD frequently occur together, the genetic architecture of BAV may also 
consist of many different genetic variants that interact in an additive manner to 
increase risk for BAV and its complications” (Prakash et al., 2014). Because the 
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association between BAV and TAAD is so strong, it is a reasonable hypothesis 
that they have a common etiology. Further supporting the hypothesis is the 
common embryological origin of the aortic valve and ascending aorta. Both the 
aortic valve and ascending aorta develop from neural crest cells early in fetal 
development (Cotrufo et al., 2005). It is reasonable to believe that a genetic 
defect specifically altering the function and development of neural crest cells 
could result in defects of both the aortic valve and the media of the ascending 
aorta.  
 While there is a possibility of a genetic link between BAV and aortic 
aneurysms, some researchers believe that the link is related to the fact that 
bicuspid aortic valves have altered biomechanics (Conti et al., 2010).  BAV 
patients are at greater risk of aortic leaflet thickening, calcification and stenosis 
resulting in abnormal flow patterns in the aortic root and ascending aorta. Fusion 
of two leaflets causes restrictions in the opening of the valve and thus the valve 
opening becomes more elliptical, and off center (Conti et al., 2010). This 
restricted cusp motion leads to blood flow deflection not seen in patients with 
normal aortic valves (Della Corte et al., 2012). According to Bissell et al (2013), 
as the valve opening becomes more narrowed, the blood flow into the aorta 
becomes more helical and less cohesive. As a result, the blood stream hits the 
aortic wall at an abnormal angle causing increased local wall shear stress. They 
hypothesize that aortic dilation is a compensatory mechanism to combat the 
increased stress caused by the abnormal blood flow. Increased wall shear stress 
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has been shown to cause increased levels of matrix metalloproteinase and other 
cellular enzymes that lead to extra cellular matrix remodeling that will eventually 
lead to aortic aneurysms (Stegemann et al., 2004). Increased sheer stress has 
also been shown to have a negative effect on vascular smooth muscle cells, 
causing a decrease in proliferation and an increase in apoptosis, which can lead 
to destruction of the aortic wall (stated above) (Stegemann et al., 2004).  
 
Surgical repair of aortic valves and aortic aneurysms 
Dysfunctional aortic valves can be surgically replaced. The two main 
reasons for valve replacement procedures are stenosis, the narrowing of the 
valve opening causing obstruction of blood flow due to thickened valve leaflets, 
or regurgitation, the back flow of blood into the left ventricle because of valve 
prolapse. Stenosis is usually the result of decades of aortic stress and calcium 
deposition on the valves from normal blood flow causing loss of mobility of the 
leaflet. Regurgitation is typically caused by leaflet failure due to the degeneration 
of the connective tissue or by changing pressure in the aorta due to dilatation. 
During an aortic valve replacement procedure, the valve is removed and 
replaced with a prosthetic valve. The replacement valve can be either biological 
in origin (usually porcine or bovine) or mechanical. Prosthetic valves typically last 
for 10-20 years and this type of surgery usually has a very low mortality rate 
(Opotowsky et al., 2013). In addition, the life expectancy of a patient suffering 
from severe stenosis and/or regurgitation is much longer if the valve is replaced. 
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Patients with congenital BAV are at higher risk for both stenosis and regurgitation 
and patients with this condition usually require a valve replacement surgery at 
some point in their lifetime (“Heart Surgery - Aortic Valve Surgery,” n.d.).  
 Similarly, aortic aneurysms require reparative surgery to prevent more 
serious aortic events such as dissection and rupture, which can be fatal. Once an 
aneurysm has been deemed to be too large (usually when the size reaches 5 cm 
or increases by 0.5 cm in a year), surgery is required to repair the aneurysm. 
During this procedure, the aneurysmal portion of the aorta is excised and 
replaced with a synthetic graft (“Aortic Aneurysm Surgery,” n.d.). Depending on 
where the aneurysm occurs on the aorta, this procedure can be done while 
sparing the aortic valve or may require an aortic valve replacement at the same 
time. Like the aortic valve replacement surgery, this procedure usually has very 
low operative risks (Opotowsky et al., 2013).  
 This is where the importance of BAV classification becomes apparent. 
Most BAV patients will need a valve replacement due to severe stenosis, 
calcification or some other pathology that renders the valve physiologically 
inadequate. Additionally, 30% of BAV patients will develop an aortic aneurysm 
and require surgical replacement of a piece of their aorta (Prakash et al., 2014). 
If the research presented above is correct, and it is confirmed that patients with 
specific BAV phenotypes have a tendency to develop a specific aortic aneurysm 
phenotype, this could lead to major changes in the methods used to treat and 
manage BAV and its related health effects. Most specifically, clinicians can tailor 
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a BAV patient’s treatment and surgical procedures based on their specific 
phenotype of BAV. For example, if a patient presents with a R-L phenotype, 
he/she is more likely to develop an aneurysm at the level of the Sinus of 
Valsalva, which tends to occur at a younger age (Della Corte et al., 2014). This 
patient will require a stricter clinical surveillance and different surgical 
arraignments (surgery at a younger age, replacement valve type, etc.) when 
compared to a patient with R-N phenotype who is less likely to develop a root 
phenotype aneurysm.  
 Furthermore, if it is confirmed that genes suspected of causing BAV truly 
do so, this may also lead to a better, more refined approach to monitoring, 
managing, and treating BAV and its associated health effects. If managed from a 
younger age, it may be possible to prevent or slow the progression of these 
adverse effects such as stenosis, calcification, or valve failure. Also, with earlier 
treatment and/or preemptive valve replacement surgery, it may be possible to 
slow down or even prevent BAV related aortic aneurysms.  
 
Current study 
 The current study aims to provide insights that will one day be used to 
advance the clinical management/treatment of BAV. We hope to achieve this aim 
by completing two objectives. First, confirm the association between BAV 
phenotype and aortic aneurysm phenotype and second, determine whether the 
association between BAV and aortic aneurysms has a genetic link or a 
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hemodynamic cause.  
The purpose of the first objective is to confirm the results of a previously 
mentioned study in hopes to support the installment and use of a universal 
classification system. The benefits of using a universal classification system have 
been discussed above and if the results of the current study confirm the 
association between different BAV phenotypes and ascending aneurysm 
phenotypes, this would support the use of such a system. In order to do so, we 
will analyze echocardiogram images of the aortic valve and ascending aorta to 
determine BAV and aortic aneurysm phenotyping. Then we will use statistical 
analysis to determine whether or not there is a direct correlation between BAV 
phenotype and aortic aneurysm phenotype.  
The purpose of the second objective is to help provide an answer to the 
debated question about the correlation between BAV and aortic aneurysms. By 
screening our participants for the genes that could potentially cause aortic 
aneurysms, we hope to identify a genetic cause and to determine if these same 
genes are somehow involved in BAV. We hope that the results of the current 
study will provide enough data to advance the treatment of BAV. Regardless of 
the outcomes, our main objective is to provide information that will one day lead 
to better clinical management of BAV in order to improve the lives and health of 
those who suffer from this common congenital disorder.   	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MATERIALS AND METHODS 
 
Patients 
 After local Institutional Review Board approval, patients were identified 
from a database of >10,000 potential bicuspid aortic valve patients collected 
between 2010 and 2015 through a variety of different sources (the majority of 
which came from a research patient data registry at Brigham and Women’s 
Hospital). Each patient was contacted and, of these 10,000 patients, 1609 
patients consented to providing a DNA sample.  For the present study, we 
selected patients who have had aortic valve replacement surgery or another type 
of cardiac surgery at a Partners-affiliated hospital (principally Brigham and 
Women’s Hospital and Massachusetts General Hospital) because we had 
greatest access to medical records for these patients and thus the necessary 
data was much more accessible for these patients. The exclusion criteria were: 
systemic disorders (Marfan syndrome, Turner syndrome, etc.), age greater than 
80 at the time of surgery, and/or previous cardiac surgery. In total, 730 patients 
were eligible for inclusion in the study.  
For the non-genetic portion of the study, we removed any patient that did 
not have a clear description of the aortic valve phenotype and aortic aneurysm 
phenotype. Patients with NC-L fusion were not considered in the study because 
of the rarity of this phenotype. The total number of remaining patients for the non-
genetic portion was 434.  For the genetic portion of the study, 452 patients with 
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clear records of aortic aneurysm phenotype were available. There was an 
overlap of 227 patients in the two arms of the study.  
 
Valve classification 
 Valve phenotype was classified as L-R (fusion between left and right 
leaflets), R-NC (fusion between right and non-coronary leaflets), or not bicuspid 
(tricuspid valves with no leaflet fusion). The bicuspid aortic valve was confirmed 
by visualization of the aortic valve when seen in an axial view of a 
transesophageal or transthoracic echocardiogram in 311 patients. For the 
remaining patients, no TEE or TTE images were available so the phenotype of 
the aortic valve was arbitrated from echocardiogram or surgical report.  
 
Aortic aneurysm classification 
 The aortic aneurysm phenotype was measured from echocardiogram or 
CT dimensions and classified as root (dilatation at the sinus of Valsalva), 
ascending (dilatation at the proximal ascending aorta), or no aneurysm. For the 
311 patients with echocardiogram images, the aorta was measured in the 
coronal view of a TEE or TTE. The sinus and proximal ascending aorta was 
measured from inner edge to inner edge during diastole. The aorta was 
determined to be aneurysmal if the ratio of the patient’s measured aortic 
diameter to the patient’s normal aortic diameter exceeded 1.15. In order to 
determine each patient’s normal aortic diameter we used the Roman formulas 
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and to determine BSA (needed for the Roman formulas) we used the Dubois 
formula (Roman et al., 1989). For the remaining patients, no TEE or TEE images 
were available so aortic aneurysm was arbitrated from echocardiogram or 
surgical report. 
 
Genome wide association study 
 All 452 patients used for the genetics portion of this study were genotyped 
using the Illumina HumanOmni2.5 BeadChip. Three dbGap cohorts (Framingham 
Heart Study, Genetic Epidemiology of Refractive Error in the KORA, The Genetic 
Architecture of Smoking and Smoke Cessation, Joint Addiction, Aging, and 
Mental Health) were used as control (tricuspid) patients and all were genotyped 
with either Human Omni2.5 or HumanOmni5.0 arrays. The quality control steps 
of the genotype data are listed in the table below (Table 1). 
 
Statistical analysis 
 For the non-genetic portion of this study, valve phenotype frequencies 
were compared by chi-square test, likelihood ratio chi-square test, and Mantel-
Haenzel chi-square test for both aneurysm phenotypes. Logistic regression 
analyses were performed to check the significance level of both BAV phenotypes 
in predicting an aneurysm of either phenotype compared to TAV and to calculate 
the odds ratios. P values were adjusted for age. A difference of least squares 
means test was used to determine if there was any significant distinction 
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between the two BAV phenotypes in predicting an aneurysm of either phenotype.  
 For the genetic portion of this study, logistic regression analysis was used 
to find association with aortic aneurysm while accounting for age and gender as 
covariates. 
 
Table 1. Quality control of genotype data  
Quality Control 
steps 
Filters BAV case cohort 
Raw genotype data Read (Bim, Bed, Fam) for 480 samples 2,379,855 markers 
Step1 Exclude markers with no-founders 2,802 markers 
Step2 Exclude markers with no-position 7,238 markers 
Step3 Exclude monomorphic markers 33 markers 
Step4 Exclude pseudo-autosomal region of X 418 markers 
Step5 Exclude mitochondrial chromosome 256 markers 
Step6 Exclude X and Y chromosomes 57,769 markers 
Step7 Exclude markers if missing rate > 10% 8,076 markers 
Step8 Exclude markers with MAF<5% 1,053,599 markers 
Step9 Markers failed HWE test (P<0.0001) 3,942 markers 
Step10- for samples Removed samples with low genotype 
rate (<95%) 
16 samples 
Step11- for samples Population stratification – detected 
outliers 
8 samples 
Step12- for samples Remove samples with no-BAV 
phenotype 
4 samples 
         Total SNPs and samples which remained after QC = 1,245,722 SNPs and 
452 samples 
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RESULTS 
 
Correlation between aortic valve phenotype and aortic aneurysm 
phenotype 
Of the 434 patients used in this portion of the study, 262 (60.3%) had a L-
R fusion pattern, 62 (14.2%) had a R-NC fusion pattern, and 110 (25.3%) had a 
tricuspid aortic valve (Table 2). For L-R fusion phenotype, 37 of the 262 patients 
(14%) presented with a root phenotype aneurysm. For R-NC fusion phenotype, 5 
of the 62 patients (8%) presented with a root phenotype aneurysm. For the TAV 
patients, 10 out of 110 (9%) presented with a root phenotype. In total, 52 of the 
434 total cases (12%) presented with a root aneurysm phenotype (Table 2).  
Only 404 patients were used in determining the frequencies of proximal 
ascending aortic aneurysms because 30 patients did not have the necessary 
data to accurately determine if an aneurysm was present or not. For L-R 
phenotype, 130 out of 258 patients (50%) were identified as having an aneurysm 
in the proximal ascending aorta. For R-NC phenotype, 37 of the 62 patients 
(60%) and 22 of the 84 TAV patients (26%) presented with this type of aneurysm 
(Table 3). In total, 189 of the 404 cases had an ascending aneurysm phenotype.  
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Table 2. Frequency of Aortic Root Aneurysm  
Valve 
Aortic root aneurysm 
present  
Not present Total 
L-R 37 (14%) 225 (86%) 262 
R-NC 5 (8%) 57 (92%) 62 
TAV 10 (9%) 100 (91%) 110 
Total 52 (12%) 382 (88%) 434 
 
 
Table 3. Frequency of Ascending Aortic Aneurysm  
Valve 
Ascending aortic 
aneurysm present 
Not present Total 
L-R 130 (50%) 128 (50%) 258 
R-NC 37 (60%) 25 (40%) 62 
TAV 22 (26%) 62 (74%) 84 
Total 189 (47%) 215 (53%) 404 
 
We observed a significant association between valve phenotype and 
proximal ascending aortic aneurysm phenotype (p<0.0001) but no association 
between valve phenotype and aortic root aneurysm phenotype (p=0.23). Using 
TAV phenotype as a reference, L-R and R-NC valves are significantly associated 
with the presence of a proximal ascending aneurysm. Patients with L-R valve 
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phenotype were three times more likely to have a proximal ascending aortic 
aneurysm and patients with a R-NC were four times more likely to have this type 
of aneurysm. These differences persisted despite adjustment for age and gender 
as covariates.  By contrast, there was no observed association between valve 
phenotype and aortic root aneurysm. 
 
Identification of loci associated with root and proximal ascending 
aneurysms 
 The GWAS was conducted on 262 cases for ascending aneurysm and 
101 cases for root aneurysm. 29 SNPs on chromosomes 8, 10, 11, 13, 14, 15, 
and 16 were found to have an association with proximal ascending aortic 
aneurysm (Table 5) and 81 SNPs on chromosomes 2, 8, and 11 were found to 
have an association with aortic root aneurysm (Table 4). However none of these 
SNPs showed significance at the GWAS level (p < 5*10-8).   
 
Table 4. Top SNPs for root aneurysms 
SNP Chromosome OR P Value 
rs13013272 2 2.3 1*10-4 
rs10108063 8 2.5 1*10-5 
rs4937879 11 2.1 2.4*10-5 
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Table 5. Top SNPs for proximal ascending aneurysms 
SNP Chromosome OR P Value 
rs12716962 16 2.1 1.2*10-5 
rs4505047 11 2.0 2.8*10-5 
rs4905932 14 0.54 9.7*10-5 
rs2812743 13 0.47 2.6*10-5 
rs10887104 10 0.33 2.5*10-5 
rs959692 8 1.8 1.1*10-4 
 
 
Table 6. Top SNPs common in both BAV and aortic aneurysms 
SNP Aneurysm Phenotype 
OR  
(for aneurysm) P Value 
rs789663 Ascending 0.49 6.4*10-5 
rs2868750 Ascending 0.38 8.3*10-5 
rs7952073 Root 2.1 6.5*10-5 
rs12274692 Root 2.1 7.4*10-5 
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DISCUSSION 
 
Association between BAV phenotype and aortic aneurysm phenotype 
 Association between bicuspid aortic valve and aortic aneurysms has been 
previously identified (Schaefer et al., 2007) and similarly, association between 
different BAV phenotypes and different aortic aneurysm phenotypes has been 
documented in the literature, with L-R valve morphology being associated with 
root aneurysm phenotype and R-NC valve morphology being associated with 
proximal ascending aneurysm phenotype has (Della Corte et al., 2014).  We 
sought to replicate these latter findings but were unable to do so. 
We did confirm an association between BAV and aortic aneurysm in our 
cohort with an approximately two-fold increased risk in this surgical population.  
This was observed for both BAV phenotypes: 142 (54%) L-R patients had an 
aneurysm and 38 (61%) of R-NC patients did as well.  
While there is a clear indication that BAV patients are at greater risk to 
develop an aortic aneurysm, once the cohort was broken down by valve 
phenotype and each aneurysm phenotype was considered separately, the 
association was not as clear. When considering the risk of developing a proximal 
ascending aneurysm, BAV patients were at a greater risk than TAV patients. 
Importantly, when considering L-R and R-NC patients separately, both BAV 
morphotypes showed a significantly increased risk for developing a proximal 
ascending aneurysm when compared to TAV patients. The data from the current 
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study suggests that L-R BAV patients have a 3-fold increased risk and R-NC 
patients have a 4-fold increased risk when comparing to TAV patients. However, 
when testing our hypothesis that the valve phenotype had impact upon the aortic 
phenotype, we did not observe an association, which was unexpected. As stated 
above, it has been shown that the R-NC valve phenotype has a greater 
association with proximal ascending aortic aneurysms. While our statistical 
analysis did not find a significant difference between L-R and R-NC for this type 
of aneurysm, the frequencies in our cohort and relative risk showed that R-NC 
patients have an increased incidence of proximal ascending aneurysms when 
compared to L-R. Sixty percent of R-NC patients presented with a proximal 
ascending aneurysm with an OR of 4.4 whereas L-R patients had a 50% 
frequency and an OR of 3.0.  Based on these results, there appears to be a 
difference between the two valve phenotypes in predicting this type of aneurysm.  
Limitations to our examination of this hypothesis may have included 
inadequate sample size as mentioned above or confounding by the mode of 
presentation in the study population.  The examined cohort was not a population 
wide sample and the majority of patients were enrolled because they sought care 
for aortic valve disease or aortic aneurysmal disease.  Nevertheless, the 
important finding is that no matter which phenotype, BAV patients are at a much 
greater risk of developing a proximal ascending aneurysm when compared to the 
normal population. Whether or not there is a difference between L-R and R-NC, 
both phenotypes presented with a frequency of incidence of greater than 50%. 
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Despite the fact that R-NC had a higher frequency, the frequency in L-R was high 
as well. Thus, the likelihood of either patient set benefitting from a different 
course of clinical care is highly unlikely. No matter what BAV phenotype, patients 
will still have to be monitored closely for proximal ascending aneurysms. 
When considering root aneurysms, the current study shows that there is 
no significant difference between any of the three valve phenotypes studied. 
Again, based on the outcomes of previous studies, these results were 
unexpected. Others have shown that patients with L-R BAV phenotype are at a 
greater risk of developing a root phenotype aneurysm; the failure of the 
association to reach statistical significance in our study suggests that this is not 
the case. But as mentioned above, this may be due to an inadequate sample 
size or confounding by mode of presentation. In our cohort, the frequency of root 
aneurysm is higher in L-R patients compared to both R-NC and TAV patients. 
Also, the OR for developing a root aneurysm is greater than 1.0 in L-R patients, 
which indicates an increased risk for this outcome when compared to TAV 
patients, and the OR is less than 1.0 for R-NC, which indicates a protective 
effect. While the increased outcome frequency for L-R phenotype patients, 14% 
vs. 9% for TAV and 8% for R-NC, and OR of 1.3 are not high enough to say that 
L-R patients are at a greater risk for root aneurysms, the incidence of a root 
aneurysm in the population is extremely low to begin with. So while a slight 
increase may not be statistically significant, clinically it may be important. Despite 
the lack of statistical significance, the frequencies presented in this study suggest 
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a need for L-R patients to be more closely monitored for root aneurysms versus 
their R-NC counterparts. For example, if a L-R patient undergoes surgery for 
their proximal ascending aneurysm (as most BAV patients eventually require), it 
may be reasonable to consider preemptively repairing the aortic root as well. If 
even a small amount of root dilatation is suspected, a surgeon can provide a 
graft for the aortic root to prevent a root aneurysm from ever occurring. This may 
not be considered for TAV or R-NC patients, but it may be viable for L-R patients, 
even if the incidence frequency is only slightly higher.  
 
Genetic link between BAV and aortic aneurysms 
 The second portion of this study focused on attempting to find a genetic 
factor associated with aortic aneurysms and to determine if those factors were 
involved in BAV as well. The results of the GWAS provided us with multiple 
SNPs that could potentially be responsible for causing aneurysms. The results 
were separated by aneurysm phenotype and the top hits for each phenotype for 
identified. While the majority of SNPs were not associated with genes, we found 
multiple notable genes associated with each aneurysm phenotype. For proximal 
ascending aneurysms the genes were IGF1R (chromosome 15), CDH13 
(chromosome 16), PARP4P2 (chromosome 13), OR52B2 (chromosome 11), 
TACC2 (chromosome 10), EVL (chromosome 14), SLC30A8 (chromosome 8), 
and WWOX (chromosome 16). For root aneurysms the associated genes were 
SFRP1 (chromosome 8), GLB1L2 (chromosome 11), and LRP1B (chromosome 
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2). At first glance these none of these genes seem to have functions that relate 
specifically to the aorta. However, most of the genes listed above code for 
proteins that could have an effect of the cellular environment that could lead to 
aneurysm formation. A few of the genes listed above code for proteins that are 
involved in regulating apoptosis; one of which specifically regulates endothelial 
cell apoptosis and is associated with atherosclerosis. As previously mentioned, 
apoptosis in the medial layer of the aorta is one of the main pathological features 
of an aneurysm. Thus some of these genes could potentially be involved in 
causing the increased frequency of apoptosis in the aortic media that leads to 
aneurysms and should be inspected further in future research.  
 Another important detail about the results from the GWAS is the fact that 
both aneurysm phenotypes have different SNPs and genes involved. This 
supports the argument that there is a distinction between root and proximal 
ascending aneurysms and that classifying patients based on these two 
phenotypes would be beneficial on a clinical level. Being able to identify if 
patients are prone to a specific type of aneurysm based on their genes could be 
monumental in treating this potentially life-threatening illness. This is especially 
important because both root aneurysms and proximal ascending aneurysms 
require different treatment and care. If a physician can assess a patient’s risk of 
developing an aneurysm simply from their genetic information,  he/she can tailor 
a preemptive course of treatment for the specific aneurysm phenotype (for which 
the patient is at risk) well before any symptoms arise.  
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 While the GWAS provided us with multiple signals, after accounting for 
multiple comparisons, none of the results proved to be statistically significant at 
the GWAS level (p<5*10-8). However, because of the low number of cases in 
each group, the power of test is not very high. So in fact these hit signals may be 
good candidate markers. In order to get validation of these results the study will 
be replicated in other cohorts.  
 Another important result from the GWAS was that multiple SNPs for aortic 
aneurysms (both phenotypes) matched SNPs previously found in BAV patients. 
However, these SNPs did not prove to be useful in linking a common genetic 
cause for aneurysms and BAV. All of the matching SNPs had weak statistical 
significance and some of them even showed a protective risk for aneurysm. Also 
the few matching SNPs belonged to genes whose function appears to have no 
correlation to either BAV or aortic aneurysms. For example, one of the SNPs that 
matched with BAV and root aneurysms belonged to the gene ACCSL on 
chromosome 11. This gene codes for an enzyme-like protein that may or may not 
have enzymatic activity. These results seem to suggest that there is no common 
genetic link between BAV and aortic aneurysms. This is not to say that there is 
no genetic cause of aneurysms, but its direct correlation to BAV does not appear 
to be genetic in nature. The genetic results indicate that there could be a genetic 
cause of aneurysm but it is unlikely to be caused by the same genes that cause 
BAV. This leads to the conclusion that, because a direct genetic link is not 
apparent, there must be, at least partly, a hemodynamic link between BAV and 
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aortic aneurysms. In all likelihood, the most likely association is a combination of 
the genetic factors discussed above and a hemodynamic effect caused by BAV. 
It is possible that hemodynamic stress caused by BAV could have an influence 
on the expression of the genes that cause aneurysms. Further studies are 
needed to first confirm the results of the GWAS and then to determine if BAV has 
any effect on the expression on the genes shown to cause aneurysms.  
 
Limitations 
 This study has limitations that may have had an effect on the results. The 
patients in the study were all cardiac surgery patients, most of whom were having 
surgery for valve replacement or aneurysm repair. Thus this could have had a 
large influence on the reported frequencies of aneurysms based on valve type, 
especially for TAV patients. Because the patients were all surgical candidates, 
frequency of aneurysms identified in them could be higher than normally 
expected. Almost all BAV patients eventually require aortic surgery so this may 
not have a major impact on those patient frequencies; however, the aneurysm 
incidence for patients with a normal aortic valve may have been over estimated 
in this study. This would have had an effect on the statistical analysis and thus 
may have caused certain data to appear insignificant. Also in this regard, the 
limited number of patients may also have had an effect. Because the cohort was 
small in size, the results may have been statistically insignificant. With a larger 
patient base, the statistical outcome may have been different. The small size 
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patient size may have had also had an effect on the GWAS results. None of the 
SNPs were considered statistically significant at the GWAS level; however, some 
were close. If the patient population had been larger, the statistical analysis may 
have been slightly different and some of the SNPs may have had a more 
significant P value. In order to account for these limitations, the study should be 
repeated with a larger patient population and a control group that is more 
representative of the normal population.  
 Another potential limitation is fact not all of the data was arbitrated by us 
personally. A portion of the data came from surgical reports that may not have 
been entirely accurate. Because much of the imaging was missing or not 
available for these patients, we could not arbitrate all of the data ourselves. Thus 
it was necessary for us to get this data from a source that we believed to be 
reliable. This does not mean the data from the surgical notes is not accurate; 
however, because we did not arbitrate it personally, we cannot truly be 100% 
sure. It is possible that errors in the data could have could have had an effect on 
the results of our study. Any future researchers that replicate our study should 
make every attempt to arbitrate all their data themselves. 
 
Conclusion 
 In conclusion, the current study has provided useful information to better 
understand BAV, aortic aneurysms, and the relationship between the two 
disorders. The limitations presented above have made it so that the results of the 
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study may not be entirely conclusive; however, they provide a good starting point 
for future studies. The unexpected results of the non-genetic portion were clear 
enough to suggest that the classification system used above can provide clinical 
benefit for both BAV and aneurysm patients. The results of the GWAS have 
provided potentially good markers that could be pursued in investigations of how 
BAV leads to aneurysms and how to better treat them. The results need to be 
replicated in a larger cohort and one day they could prove to be helpful in the 
clinical setting. 
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